309 related articles for article (PubMed ID: 18816788)
21. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
Straiker A; Mackie K
J Physiol; 2005 Dec; 569(Pt 2):501-17. PubMed ID: 16179366
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Hampson RE; Miller F; Palchik G; Deadwyler SA
Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
[TBL] [Abstract][Full Text] [Related]
23. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon.
Storr M; Sibaev A; Marsicano G; Lutz B; Schusdziarra V; Timmermans JP; Allescher HD
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G110-7. PubMed ID: 12893627
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid CB
Leonard MZ; Alapafuja SO; Ji L; Shukla VG; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
J Pharmacol Exp Ther; 2017 Dec; 363(3):314-323. PubMed ID: 28947487
[TBL] [Abstract][Full Text] [Related]
26. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala.
Roberto M; Cruz M; Bajo M; Siggins GR; Parsons LH; Schweitzer P
Neuropsychopharmacology; 2010 Aug; 35(9):1962-72. PubMed ID: 20463657
[TBL] [Abstract][Full Text] [Related]
27. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
Fawley JA; Hofmann ME; Andresen MC
J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
[TBL] [Abstract][Full Text] [Related]
29. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus.
Takahashi KA; Castillo PE
Neuroscience; 2006; 139(3):795-802. PubMed ID: 16527424
[TBL] [Abstract][Full Text] [Related]
30. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Silva GB; Atchison DK; Juncos LI; García NH
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
[TBL] [Abstract][Full Text] [Related]
31. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
Németh B; Ledent C; Freund TF; Hájos N
Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid modulation of neuronal function after oxygen/glucose deprivation in area CA1 of the rat hippocampus.
Youssef FF; Hormuzdi SG; Irving AJ; Frenguelli BG
Neuropharmacology; 2007 May; 52(6):1327-35. PubMed ID: 17382973
[TBL] [Abstract][Full Text] [Related]
33. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.
Adermark L; Lovinger DM
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20564-9. PubMed ID: 18077376
[TBL] [Abstract][Full Text] [Related]
34. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex.
Cass DK; Flores-Barrera E; Thomases DR; Vital WF; Caballero A; Tseng KY
Mol Psychiatry; 2014 May; 19(5):536-43. PubMed ID: 24589887
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
Romano MR; Lograno MD
Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
[TBL] [Abstract][Full Text] [Related]
36. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing.
Eroli F; Loonen ICM; van den Maagdenberg AMJM; Tolner EA; Nistri A
Neuropharmacology; 2018 Mar; 131():39-50. PubMed ID: 29225040
[TBL] [Abstract][Full Text] [Related]
37. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.
Ronesi J; Gerdeman GL; Lovinger DM
J Neurosci; 2004 Feb; 24(7):1673-9. PubMed ID: 14973237
[TBL] [Abstract][Full Text] [Related]
38. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
Gerdeman G; Lovinger DM
J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
[TBL] [Abstract][Full Text] [Related]
39. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
Maccarrone M; Rossi S; Bari M; De Chiara V; Fezza F; Musella A; Gasperi V; Prosperetti C; Bernardi G; Finazzi-Agrò A; Cravatt BF; Centonze D
Nat Neurosci; 2008 Feb; 11(2):152-9. PubMed ID: 18204441
[TBL] [Abstract][Full Text] [Related]
40. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Hájos N; Ledent C; Freund TF
Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
